Detalhe da pesquisa
1.
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Cytokine
; 177: 156543, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373365
2.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513973
3.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Exp Parasitol
; 251: 108555, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247802
4.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
5.
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
Pathogens
; 12(2)2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839586
6.
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Biology (Basel)
; 12(6)2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372136
7.
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Acta Trop
; 246: 106986, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453579